Use of transthyretin as a biomarker for colorectal adenoma; method for detection and test system

Details for Australian Patent Application No. 2004322162 (hide)

Owner Indivumed GmbH

Inventors David, Kerstin; Juhl, Hartmut

Agent Fisher Adams Kelly

Pub. Number AU-B-2004322162

PCT Pub. Number WO2006/015616

Filing date 13 August 2004

Wipo publication date 16 February 2006

Acceptance publication date 28 April 2011

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

22 February 2007 PCT application entered the National Phase

  PCT publication WO2006/015616 Priority application(s): WO2006/015616

10 May 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 07 Mar 2007 and 22 Mar 2007 2005

28 April 2011 Application Accepted

  Published as AU-B-2004322162

25 August 2011 Standard Patent Sealed

8 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004322167-Intervertebral implant

2004322161-Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid